Experimental and Molecular Medicine (Sep 2024)

IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage–myofibroblast transition

  • Hyang Hee Cho,
  • Siyeon Rhee,
  • Dong Im Cho,
  • Ju Hee Jun,
  • HyoJung Heo,
  • Su Han Cho,
  • Dohyup Kim,
  • Mingqiang Wang,
  • Bo Gyeong Kang,
  • Soo Ji Yoo,
  • Meeyoung Cho,
  • Soo yeon Lim,
  • Jae Yeong Cho,
  • In Seok Jeong,
  • Yong Sook Kim,
  • Youngkeun Ahn

DOI
https://doi.org/10.1038/s12276-024-01304-0
Journal volume & issue
Vol. 56, no. 9
pp. 2052 – 2064

Abstract

Read online

Abstract The regulatory role of the inhibitor of NF-kB kinase ε (IKKε) in postmyocardial infarction (MI) inflammation remains uncertain. Using an MI mouse model, we examined the cardiac outcomes of IKKε knockout (KO) mice and wild-type mice. We employed single-cell RNA sequencing (scRNA-seq) and phosphorylated protein array techniques to profile cardiac macrophages. IKKε KO mice exhibited compromised survival, heightened inflammation, pronounced cardiac fibrosis, and a reduced ejection fraction. A distinct cardiac macrophage subset in IKKε KO mice exhibited increased fibrotic marker expression and decreased phosphorylated p38 (p-p38) levels, indicating an enhanced macrophage–myofibroblast transition (MMT) post-MI. While cardiac inflammation is crucial for initiating compensatory pathways, the timely resolution of inflammation was impaired in the IKKε KO group, while the MMT in macrophages accelerated post-MI, leading to cardiac failure. Additionally, our study highlighted the potential of 5-azacytidine (5-Aza), known for its anti-inflammatory and cardioprotective effects, in restoring p-p38 levels in stimulated macrophages. The administration of 5-Aza significantly reduced the MMT in cardiac macrophages from the IKKε KO group. These findings underscore the regulation of the inflammatory response and macrophage transition by the IKKε-p38 axis, indicating that the MMT is a promising therapeutic target for ischemic heart disease.